Literature DB >> 17497175

Genetic variation in catechol-O-methyltransferase (COMT) and obesity in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial.

Sophia S Wang1, Lindsay M Morton, Andrew W Bergen, Elizabeth Z Lan, Nilanjan Chatterjee, Paul Kvale, Richard B Hayes, Stephen J Chanock, Neil E Caporaso.   

Abstract

Catechol-O-methyltransferase (COMT) is an important modulator in the catabolism of extraneural dopamine, which plays an important role in drug reward mechanisms. It is hypothesized that genetic variations in the COMT gene, which can result in a three to fourfold difference in COMT enzyme activity, may be associated with several reward-motivated behaviors. The aim of our study was to examine the relationship between COMT polymorphisms with smoking, obesity and alcohol. Three single nucleotide polymorphisms (SNPs) in COMT were genotyped in 2,371 participants selected randomly from the screening arm of the PLCO Cancer Screening Trial after stratifying by sex, age, and smoking status. Smoking, obesity, and alcohol consumption were assessed by questionnaire. SNP and haplotype associations were estimated using odds ratios (ORs) and 95% confidence intervals (CIs) derived from conditional logistic regression models, adjusted for race/ethnicity. The COMT Ex4-76C > G (Leu136Leu) polymorphism was statistically significantly associated with individuals who had >30% increases in BMI from ages 20 to 50 years, compared to those with 0-5% increase in BMI (0-5%) over the same age period: (CC is referent; OR(CG )= 1.42, OR(GG )= 1.46, P (trend )= 0.06). By sex, the increased risk was further pronounced among females (OR(CG )= 1.50, OR(GG )= 2.10, P (trend )= 0.03). Consistent with our analyses of single polymorphisms, individuals whose BMI increased >30% from ages 20 to 50 years were more likely than individuals with 0-5% increases in BMI to possess COMT haplotypes [COMT Ex3-104C > T-COMT Ex4-76 C > G-COMT Ex4-12 A > G] that included the variant allele for COMT Ex4-76 C > G: C-G-G (T-C-A is referent: OR(C-G-G )= 1.33, 95% CI 1.01-1.77) and C-G-A (OR(C-G-A )= 1.79, 95% CI 0.72-4.49). We observed no association between any of the COMT polymorphisms with smoking behavior or alcohol intake. The COMT Ex4-76C > G (Leu136Leu) polymorphism appears to play a role in large increases in BMI. The null association with smoking and alcohol and the pronounced association with increasing BMI among women further implicates COMT's role in estrogen metabolism as a potentially culpable pathway. Our results support a need for comprehensive evaluation of COMT variations and their functional relevance as COMT may be an important molecular target to evaluate for new treatments regarding obesity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17497175     DOI: 10.1007/s00439-007-0374-7

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   5.881


  32 in total

1.  Genetic influence on smoking--a study of male twins.

Authors:  D Carmelli; G E Swan; D Robinette; R Fabsitz
Journal:  N Engl J Med       Date:  1992-09-17       Impact factor: 91.245

Review 2.  Dopaminergic genes and substance abuse.

Authors:  G R Uhl; D J Vandenbergh; L A Rodriguez; L Miner; N Takahashi
Journal:  Adv Pharmacol       Date:  1998

3.  COMT polymorphisms and anxiety-related personality traits.

Authors:  Murray B Stein; Margaret Daniele Fallin; Nicholas J Schork; Joel Gelernter
Journal:  Neuropsychopharmacology       Date:  2005-11       Impact factor: 7.853

4.  Lack of association between the functional variant of the catechol-o-methyltransferase (COMT) gene and early-onset alcoholism associated with severe antisocial behavior.

Authors:  T Hallikainen; H Lachman; T Saito; J Volavka; J Kauhanen; J T Salonen; O P Ryynänen; M Koulu; M K Karvonen; T Pohjalainen; E Syvälahti; J Hietala; J Tiihonen
Journal:  Am J Med Genet       Date:  2000-06-12

5.  Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Authors:  P C Prorok; G L Andriole; R S Bresalier; S S Buys; D Chia; E D Crawford; R Fogel; E P Gelmann; F Gilbert; M A Hasson; R B Hayes; C C Johnson; J S Mandel; A Oberman; B O'Brien; M M Oken; S Rafla; D Reding; W Rutt; J L Weissfeld; L Yokochi; J K Gohagan
Journal:  Control Clin Trials       Date:  2000-12

6.  Genetic origins of anxiety in women: a role for a functional catechol-O-methyltransferase polymorphism.

Authors:  Mary-Anne Enoch; Ke Xu; Erica Ferro; Claudia R Harris; David Goldman
Journal:  Psychiatr Genet       Date:  2003-03       Impact factor: 2.458

7.  SNP500Cancer: a public resource for sequence validation and assay development for genetic variation in candidate genes.

Authors:  Bernice R Packer; Meredith Yeager; Brian Staats; Robert Welch; Andrew Crenshaw; Maureen Kiley; Andrew Eckert; Michael Beerman; Edward Miller; Andrew Bergen; Nathaniel Rothman; Robert Strausberg; Stephen J Chanock
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

Review 8.  Obesity and cancer.

Authors:  Eugenia E Calle; Michael J Thun
Journal:  Oncogene       Date:  2004-08-23       Impact factor: 9.867

9.  Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex.

Authors:  E M Tunbridge; D M Bannerman; T Sharp; P J Harrison
Journal:  J Neurosci       Date:  2004-06-09       Impact factor: 6.167

10.  Distinct pharmacological regulation of evoked dopamine efflux in the amygdala and striatum of the rat in vivo.

Authors:  P A Garris; R M Wightman
Journal:  Synapse       Date:  1995-07       Impact factor: 2.562

View more
  8 in total

1.  No association between germline variation in catechol-O-methyltransferase and colorectal cancer survival in postmenopausal women.

Authors:  Michael N Passarelli; Polly A Newcomb; Karen W Makar; Andrea N Burnett-Hartman; Amanda I Phipps; Sean P David; Li Hsu; Tabitha A Harrison; Carolyn M Hutter; David J Duggan; Emily White; Andrew T Chan; Ulrike Peters
Journal:  Menopause       Date:  2014-04       Impact factor: 2.953

Review 2.  Neurogenetic and Neuroimaging Evidence for a Conceptual Model of Dopaminergic Contributions to Obesity.

Authors:  Ansley Grimes Stanfill; Yvette Conley; Ann Cashion; Carol Thompson; Ramin Homayouni; Patricia Cowan; Donna Hathaway
Journal:  Biol Res Nurs       Date:  2015-01-09       Impact factor: 2.522

3.  Green tea polyphenols reduce body weight in rats by modulating obesity-related genes.

Authors:  Chuanwen Lu; Wenbin Zhu; Chwan-Li Shen; Weimin Gao
Journal:  PLoS One       Date:  2012-06-08       Impact factor: 3.240

4.  The influence of dopamine-beta-hydroxylase and catechol O-methyltransferase gene polymorphism on the efficacy of insulin detemir therapy in patients with type 2 diabetes mellitus.

Authors:  Nela Pivac; Fran Borovecki; Tomislav Bozek; Antonela Blazekovic; Matea Nikolac Perkovic; Kristina Gotovac Jercic; Aleksandra Sustar; Lea Smircic-Duvnjak; Tiago F Outeiro
Journal:  Diabetol Metab Syndr       Date:  2017-12-04       Impact factor: 3.320

5.  Anthropometric measures and serum estrogen metabolism in postmenopausal women: the Women's Health Initiative Observational Study.

Authors:  Hannah Oh; Sally B Coburn; Charles E Matthews; Roni T Falk; Erin S LeBlanc; Jean Wactawski-Wende; Joshua Sampson; Ruth M Pfeiffer; Louise A Brinton; Nicolas Wentzensen; Garnet L Anderson; JoAnn E Manson; Chu Chen; Oleg Zaslavsky; Xia Xu; Britton Trabert
Journal:  Breast Cancer Res       Date:  2017-03-11       Impact factor: 6.466

6.  SLC6A3 and body mass index in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Authors:  Elizabeth M Azzato; Lindsay M Morton; Andrew W Bergen; Sophia S Wang; Nilanjan Chatterjee; Paul Kvale; Meredith Yeager; Richard B Hayes; Stephen J Chanock; Neil E Caporaso
Journal:  BMC Med Genet       Date:  2009-01-30       Impact factor: 2.103

7.  Polymorphisms of serotonin receptor 2A and 2C genes and COMT in relation to obesity and type 2 diabetes.

Authors:  Sofia I I Kring; Thomas Werge; Claus Holst; Søren Toubro; Arne Astrup; Torben Hansen; Oluf Pedersen; Thorkild I A Sørensen
Journal:  PLoS One       Date:  2009-08-19       Impact factor: 3.240

8.  Interaction Between Environmental Risk Factors and Catechol-O-Methyltransferase (COMT) and X-Ray Repair Cross-Complementing Protein 1 (XRCC1) Gene Polymorphisms in Risk of Lung Cancer Among Non-Smoking Chinese Women: A Case-Control Study.

Authors:  Jian-Liang Pan; Jin Gao; Jian-Hua Hou; De-Zhong Hu; Lin Li
Journal:  Med Sci Monit       Date:  2018-08-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.